Efficacy and safety of rivaroxaban in extreme elderly patients with atrial fibrillation: Analysis of the Shikoku Rivaroxaban Registry Trial (SRRT).

CONCLUSION: These results suggest that rivaroxaban is effective and safe in extreme elderly patients with atrial fibrillation. PMID: 28969968 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28969968?dopt=Abstract

Source: Journal of Cardiology - September 29, 2017 Category: Cardiology Authors: Bando S, Nishikado A, Hiura N, Ikeda S, Kakutani A, Yamamoto K, Kaname N, Fukatani M, Takagi Y, Yukiiri K, Fukuda Y, Nakaya Y Tags: J Cardiol Source Type: research